- Home
- RIGL vs FMAO Comparison
RIGL vs FMAO Comparison
Compare RIGL & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- FMAO
- Stock Information
- Founded
- RIGL 1996
- FMAO 1897
- Country
- RIGL United States
- FMAO United States
- Employees
- RIGL N/A
- FMAO N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- FMAO Savings Institutions
- Sector
- RIGL Health Care
- FMAO Finance
- Exchange
- RIGL Nasdaq
- FMAO Nasdaq
- Market Cap
- RIGL 335.5M
- FMAO 356.9M
- IPO Year
- RIGL 2000
- FMAO N/A
- Fundamental
- Price
- RIGL $38.85
- FMAO $26.13
- Analyst Decision
- RIGL Buy
- FMAO
- Analyst Count
- RIGL 5
- FMAO 0
- Target Price
- RIGL $38.20
- FMAO N/A
- AVG Volume (30 Days)
- RIGL 995.6K
- FMAO 21.8K
- Earning Date
- RIGL 08-05-2025
- FMAO 10-29-2025
- Dividend Yield
- RIGL N/A
- FMAO 3.34%
- EPS Growth
- RIGL N/A
- FMAO 38.39
- EPS
- RIGL 5.43
- FMAO 2.16
- Revenue
- RIGL $267,921,000.00
- FMAO $108,632,000.00
- Revenue This Year
- RIGL $59.93
- FMAO $1.60
- Revenue Next Year
- RIGL N/A
- FMAO $13.77
- P/E Ratio
- RIGL $7.15
- FMAO $12.26
- Revenue Growth
- RIGL 105.62
- FMAO 13.86
- 52 Week Low
- RIGL $12.66
- FMAO $20.88
- 52 Week High
- RIGL $43.72
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- RIGL 68.57
- FMAO 58.09
- Support Level
- RIGL $39.00
- FMAO $24.60
- Resistance Level
- RIGL $42.08
- FMAO $27.01
- Average True Range (ATR)
- RIGL 2.32
- FMAO 0.81
- MACD
- RIGL -0.37
- FMAO 0.23
- Stochastic Oscillator
- RIGL 53.26
- FMAO 89.44
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.